Overview


According to FutureWise analysis the market for airway or lung stents is expected to register a CAGR of 6.70% from 2023-2031.

An airway stent, also known as a tracheobronchial prosthesis, is a tube-shaped device with a specialized hollow lumen inserted into the airway and made from various materials. Their placement usually occurs bronchoscopically and is used to treat an array of large airway diseases. Its primary function is to provide support and ensure the openness of the tubular airway structure. This intervention can serve multiple purposes: It may prevent the extension of tumors into the airway, assist in the healing or management of airway fistulas, or provide reinforcement to the airway wall, preventing collapse or external compression.

Airway stenting is recommended for a range of both malignant and benign conditions. Regardless of the specific indication, the thoracic surgeon or interventional pulmonologist must confirm that the patient doesn't have surgically treatable airway disease before stent placement. In some cases, stenting may complicate or even rule out surgical options, particularly if it extends the lesion to over 4 cm in length, which is a commonly used limit for tracheal resection. Additionally, the placement of an airway stent can lead to local inflammation and mucosal damage that might hinder the healing process after airway resection and reconstruction. The primary reasons for stenting typically involve reducing external compression from tumors or lymphadenopathy, ensuring openness following bronchoscopic tumor removal due to internal obstruction, facilitating the healing of airway fistulas and anastomotic dehiscence post lung transplantation, and addressing specific cases of benign airway disease. As a general guideline, metallic stents are not the first-line treatment for patients with mild airway obstruction and should only be considered if all other options have been exhausted.

FutureWise Market Research has published a report that provides an insightful analysis of Airway or Lung Stents Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Airway or Lung Stents Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Boston Scientific Corp.
  • Taewoong Medical Co.
  • Novatech SA
  • Cook Group
  • Merit Medical Systems Inc.
  • Endo flex GmbH
  • EFER ENDOSCOPY
  • ENDO-FLEX GmbH
  • Standard Sci. Tech Inc
  • Stening SRL

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Development in Airway or Lung Stents Market:

  • In June 2022, Boston Scientific bid for USD 230 million to acquire M.I.Tech, a South Korean manufacturer specializing in gastrointestinal and airway stents. This acquisition is anticipated to grant Boston Scientific ownership of approximately 64% of M.I.Tech.

  • In February 2022, Micro-Tech Endoscopy unveiled the inaugural self-expanding tracheobronchial nitinol y-stent. This Y-shaped tracheal Stent System is meticulously designed to be a flexible, adaptable tool for treating malignant neoplasms at the tracheobronchial carina.

Major drivers for the market growth are the upsurge in the respiratory disorders fostering the market growth. Ever–rising technological advancements and innovations of new medical devices and their usage are also a growth factor. Surging awareness about the benefits of minimally invasive procedures in less time and its incorporation in lung stents is increasing its demand and driving the market growth. Implementing these stents offers better patient compliance and aids in maintaining optimal levels of vessel patency. Placement of the lung stent is among the preferred choices in treating malignant airway lesions due to their satisfactory clinical outcomes and reduced surgical complications; shorter hospital stays, rapid recovery, and effective management of post-surgical pain are other factors that accelerate the market growth. 

However, the market is affected by significant restraints, such as a need for more awareness in developing nations. Also, the lack of qualified and skilled medical professionals hampers the market growth as they are not readily available everywhere and are limited to the big cities. Stents can cause increased mucus production in the airways, leading to potential plugging and respiratory distress and affecting the market growth. High cost is a significant restraint for this market as the surgical procedures are very costly and hence are less affordable to the lower socioeconomic strata of the population, thus hampering the market growth.

By Product

  • Tracheobronchial Stents
  • Laryngeal Stents

By Material

  • Metal Stents
    • Nitinol Stents
    • Stainless Steel Stents
  • Silicone Stents
  • Hybrid Stents
  • Others Stents

By End User

  • Hospitals
  • Ambulatory Surgery Centres

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

The Asia Pacific region is experiencing an ascending development in healthcare industry owing to an increase in the prevalence of lung cancer and other chronic respiratory diseases, increased spending capability of the patient population and expansion of private sector hospitals.

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process. 

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America holds the largest share of the market due to the high prevalence of airway lung diseases, well-established health infrastructure, early adoption of technological advancements, and high healthcare expenditure. In addition, government and non-government organizations undertaking initiatives are playing a significant role in raising funds and promoting advanced healthcare technologies, creating awareness by organizing campaigns and celebrating specific days to help the affected individuals and for the understanding of the whole population increase the overall revenue of the market.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Global Airway Or Lung Stents Market By Product, By Material, By End User, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Airway or Lung Stents Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Airway or Lung Stents Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Airway or Lung Stents Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Airway or Lung Stents Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Tracheobronchial Stents
        2. Laryngeal Stents

  • 8.   Global Airway or Lung Stents Market, By Material Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Metal Stents
         1.1. Nitinol Stents
         1.2. Stainless Steel Stents
        2. Silicone Stents
        3. Hybrid Stents
        4. Others Stents

  • 9.   Global Airway or Lung Stents Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital
        2. Ambulatory Surgery Centres

  • 10.   North America Airway or Lung Stents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Airway or Lung Stents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Airway or Lung Stents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Airway or Lung Stents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Boston Scientific Corp.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Taewoong Medical Co.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Novatech SA
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Cook Group
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Merit Medical Systems Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Endo flex GmbH
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. EFER ENDOSCOPY
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. ENDO-FLEX GmbH
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Standard Sci. Tech Inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Stening SRL
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients